Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug;36(8):e70165.
doi: 10.1111/pai.70165.

Genotypes in the 17q12-q21 asthma risk locus and early-life viral wheezing illnesses

Collaborators, Affiliations

Genotypes in the 17q12-q21 asthma risk locus and early-life viral wheezing illnesses

Nathan Schoettler et al. Pediatr Allergy Immunol. 2025 Aug.
No abstract available

Keywords: 17q12‐q21; asthma; childhood; respiratory syncytial virus; rhinovirus; viral wheezing.

PubMed Disclaimer

Conflict of interest statement

L.B.B. is a member of the GINA Science Committee; reports grants from NIH/NIAID/NHLBI, personal fees from GlaxoSmithKline, Genentech/Novartis, Merck, Teva, Boehringer Ingelheim, AstraZeneca, Avillion, WebMD/Medscape, Sanofi/Regeneron, Vectura, Circassia, OM Pharma, Recludix, and Kinaset; for DSMB from AstraZeneca, DBV Technologies, Aravax, and Vertex; and royalties from Elsevier outside the submitted work. S.V.L. serves on the board of directors for Siolta Therapeutics Inc. and holds stock options for this company. D.J.J. reports grants from NIAID/NHLBI, GSK, and Regeneron. Personal fees for consulting from AstraZeneca, Avillion, Genentech, GSK, Regeneron, Sanofi, and DSMB for Pfizer and AstraZeneca. T.V.H. serves as the Chair of the vaccine and immunization initiative for the American Thoracic Society and on a Data Safety Monitoring Board for respiratory syncytial virus vaccines for Pfizer and reported grants from NIH and the World Health Organization and Bill and Melinda Gates Foundation during the conduct of the study and personal fees from the NIH, Parker B. Francis Foundation Council of Scientific Advisors, American Thoracic Society, Pfizer, and Sanofi outside the submitted work. J.E.G. reports grants from NIH during the conduct of the study, personal fees from Arrowhead Pharmaceuticals, AstraZeneca, and Meissa Vaccines Inc., and stock options for Meissa Vaccines Inc. outside the submitted work. No other conflicts reported by other authors.

Figures

FIGURE 1
FIGURE 1
Time‐to‐viral wheezing illness and 17q12‐q21 genotypes. Kaplan–Meier curves for time to wheezing illness for the core‐rs7216389 SNP. Separate plots are shown for results stratified by virus and parent‐reported race. p values are from the log‐rank test. The numbers of children in each group at each timepoint are shown at the bottom of each panel.

References

    1. Jackson DJ, Gangnon RE, Evans MD, et al. Wheezing rhinovirus illnesses in early life predict asthma development in high‐risk children. Am J Respir Crit Care Med. 2008;178(7):667‐672. - PMC - PubMed
    1. Rosas‐Salazar C, Chirkova T, Gebretsadik T, et al. Respiratory syncytial virus infection during infancy and asthma during childhood in the USA (INSPIRE): a population‐based, prospective birth cohort study. Lancet. 2023;401(10389):1669‐1680. - PMC - PubMed
    1. Caliskan M, Bochkov YA, Kreiner‐Moller E, et al. Rhinovirus wheezing illness and genetic risk of childhood‐onset asthma. N Engl J Med. 2013;368(15):1398‐1407. - PMC - PubMed
    1. Moffatt MF, Kabesch M, Liang L, et al. Genetic variants regulating ORMDL3 expression contribute to the risk of childhood asthma. Nature. 2007;448(7152):470‐473. - PubMed
    1. Pividori M, Schoettler N, Nicolae DL, Ober C, Im HK. Shared and distinct genetic risk factors for childhood‐onset and adult‐onset asthma: genome‐wide and transcriptome‐wide studies. Lancet Respir Med. 2019;7(6):509‐522. - PMC - PubMed

LinkOut - more resources